IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $150,499,000 | +42.6% | 1,769,944 | -27.6% | 0.07% | +35.2% |
| Q2 2020 | $105,551,000 | +336.4% | 2,445,586 | +36.3% | 0.05% | +237.5% |
| Q1 2020 | $24,184,000 | -33.0% | 1,794,086 | +5.1% | 0.02% | -15.8% |
| Q4 2019 | $36,116,000 | +200.4% | 1,706,786 | +88.2% | 0.02% | +171.4% |
| Q3 2019 | $12,024,000 | -4.4% | 906,786 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $12,577,000 | -27.8% | 906,786 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $17,419,000 | +57.3% | 906,786 | +16.9% | 0.01% | +28.6% |
| Q4 2018 | $11,072,000 | -31.5% | 775,886 | 0.0% | 0.01% | -12.5% |
| Q3 2018 | $16,162,000 | -12.0% | 775,886 | 0.0% | 0.01% | -11.1% |
| Q2 2018 | $18,365,000 | +62.0% | 775,886 | +0.0% | 0.01% | +50.0% |
| Q1 2018 | $11,334,000 | -9.6% | 775,800 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $12,537,000 | – | 775,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |